About Ataraxis AI
Ataraxis is a clinical AI research lab working at the intersection of multi-modal AI and precision medicine. Our goal is to make disease predictable. To accomplish this, we develop new AI methods that predict patient outcomes and treatment response, and build clinical tools to assist physicians in selecting the most optimal treatments for their patients.
Our AI research lab discovers and develops methods to recognize patterns and predict outcomes across complex, multi-modal clinical data. This spans our causality (Ataraxis™ Tau), foundation model (Falcon and Kestrel for digital pathology), and survival analysis research.
Our first clinical products, such as Ataraxis™ Breast for breast cancer, already help patients get the most appropriate treatment across the best academic institutions and community clinics worldwide.
At Ataraxis, you will have a unique opportunity to shape not only the future of our company, but also the future of healthcare. You will join an exceptional team at the forefront of clinical AI research and deployment. Our advisors include AI pioneers such as our founding advisor, Yann LeCun, and distinguished oncologists from top cancer research institutions, all united by the mission to redefine precision medicine.
Ataraxis has raised over $24 million in funding, including a $20 million Series A led by top venture capital funds such as Thiel Capital/Founders Fund (OpenAI, SpaceX, Palantir), Obvious Ventures (AMI Labs, Inceptive, Radical Numerics, Recursion), and AIX Ventures (Hugging Face, Perplexity).
We are an company with a flat organizational structure, where every team member is empowered to actively contribute. Leadership roles are earned by those who demonstrate initiative and consistently deliver exceptional results. Strong work ethic and the ability to prioritize ruthlessly are essential.
Responsibilities
Aggressively drive sales growth and market penetration of Ataraxis oncology products through direct sales to individual oncologists within your designated territory.
Prospecting new business and maintaining relationships.
Qualifications
Minimum 2 years of demonstrated high-performance sales experience in oncology, especially in breast cancer.
Proven track record of consistently exceeding sales quotas and demonstrated achievement through awards or recognition (e.g., President's Club, Rookie of the Year).
Passionate about AI and innovation in healthcare, driven to learn and effectively communicate AI-based diagnostic solutions.
Autonomous, capable of excelling independently in a hyper-growth start-up environment.
Ability to thrive in a highly competitive environment; demonstrates resilience, urgency, and focus on closing deals.
Ataraxis AI is a clinical AI research lab developing multi-modal AI methods to predict patient outcomes and treatment response in precision medicine. The company creates AI tools that help physicians select optimal treatments, with research spanning causality analysis (Ataraxis™ Tau), foundation models for digital pathology (Falcon and Kestrel), and survival analysis. Their first clinical product, Ataraxis™ Breast, assists in breast cancer treatment selection and is deployed across academic institutions and community clinics worldwide. The company is backed by prominent venture capital firms including Thiel Capital/Founders Fund and Obvious Ventures, with advisors including AI pioneer Yann LeCun and distinguished oncologists from top cancer research institutions.
